Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

D. E. Furst; E. C. Keystone; J. Braun; F. C. Breedveld; G. R. Burmester; F. De Benedetti; T. Doerner; P. Emery; R. Fleischmann; A. Gibofsky; J. R. Kalden; A. Kavanaugh; Bruce Kirkham; P. Mease; J. Sieper; N. G. Singer; J. S. Smolen; P. L. C. M. Van Riel; M. H. Weisman; K. Winthrop

doi:10.1136/ard.2010.146852

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

D. E. Furst^*, E. C. Keystone, J. Braun, F. C. Breedveld, G. R. Burmester, F. De Benedetti, T. Doerner, P. Emery, R. Fleischmann, A. Gibofsky, J. R. Kalden, A. Kavanaugh, Bruce Kirkham, P. Mease, J. Sieper, N. G. Singer, J. S. Smolen, P. L. C. M. Van Riel, M. H. Weisman, K. Winthrop

^*Corresponding author for this work

Research output: Contribution to journal › Literature review › peer-review

80 Citations (Scopus)

Original language	English
Pages (from-to)	I2-I36
Number of pages	35
Journal	Annals of the Rheumatic Diseases
Volume	70
Issue number	Suppl 1
DOIs	https://doi.org/10.1136/ard.2010.146852
Publication status	Published - Mar 2011

Keywords

TUMOR-NECROSIS-FACTOR
SYSTEMIC-LUPUS-ERYTHEMATOSUS
B-CELL DEPLETION
JUVENILE IDIOPATHIC ARTHRITIS
ALPHA MONOCLONAL-ANTIBODY
INTERLEUKIN-1 RECEPTOR ANTAGONIST
FAMILIAL MEDITERRANEAN FEVER
PLACEBO-CONTROLLED TRIAL
ACTIVE ANKYLOSING-SPONDYLITIS
MODIFYING ANTIRHEUMATIC DRUGS

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/ard.2010.146852

Cite this

Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Doerner, T., Emery, P., Fleischmann, R., Gibofsky, A., Kalden, J. R., Kavanaugh, A., Kirkham, B., Mease, P., Sieper, J., Singer, N. G., Smolen, J. S., Van Riel, P. L. C. M., Weisman, M. H., & Winthrop, K. (2011). Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010. Annals of the Rheumatic Diseases, 70(Suppl 1), I2-I36. https://doi.org/10.1136/ard.2010.146852

@article{5595e812d36a4a89959bf0098a095eea,

title = "Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010",

keywords = "TUMOR-NECROSIS-FACTOR, SYSTEMIC-LUPUS-ERYTHEMATOSUS, B-CELL DEPLETION, JUVENILE IDIOPATHIC ARTHRITIS, ALPHA MONOCLONAL-ANTIBODY, INTERLEUKIN-1 RECEPTOR ANTAGONIST, FAMILIAL MEDITERRANEAN FEVER, PLACEBO-CONTROLLED TRIAL, ACTIVE ANKYLOSING-SPONDYLITIS, MODIFYING ANTIRHEUMATIC DRUGS",

author = "Furst, {D. E.} and Keystone, {E. C.} and J. Braun and Breedveld, {F. C.} and Burmester, {G. R.} and {De Benedetti}, F. and T. Doerner and P. Emery and R. Fleischmann and A. Gibofsky and Kalden, {J. R.} and A. Kavanaugh and Bruce Kirkham and P. Mease and J. Sieper and Singer, {N. G.} and Smolen, {J. S.} and {Van Riel}, {P. L. C. M.} and Weisman, {M. H.} and K. Winthrop",

year = "2011",

month = mar,

doi = "10.1136/ard.2010.146852",

language = "English",

volume = "70",

pages = "I2--I36",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "Suppl 1",

}

Furst, DE, Keystone, EC, Braun, J, Breedveld, FC, Burmester, GR, De Benedetti, F, Doerner, T, Emery, P, Fleischmann, R, Gibofsky, A, Kalden, JR, Kavanaugh, A, Kirkham, B, Mease, P, Sieper, J, Singer, NG, Smolen, JS, Van Riel, PLCM, Weisman, MH & Winthrop, K 2011, 'Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010', Annals of the Rheumatic Diseases, vol. 70, no. Suppl 1, pp. I2-I36. https://doi.org/10.1136/ard.2010.146852

TY - JOUR

T1 - Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

AU - Furst, D. E.

AU - Keystone, E. C.

AU - Braun, J.

AU - Breedveld, F. C.

AU - Burmester, G. R.

AU - De Benedetti, F.

AU - Doerner, T.

AU - Emery, P.

AU - Fleischmann, R.

AU - Gibofsky, A.

AU - Kalden, J. R.

AU - Kavanaugh, A.

AU - Kirkham, Bruce

AU - Mease, P.

AU - Sieper, J.

AU - Singer, N. G.

AU - Smolen, J. S.

AU - Van Riel, P. L. C. M.

AU - Weisman, M. H.

AU - Winthrop, K.

PY - 2011/3

Y1 - 2011/3

KW - TUMOR-NECROSIS-FACTOR

KW - SYSTEMIC-LUPUS-ERYTHEMATOSUS

KW - B-CELL DEPLETION

KW - JUVENILE IDIOPATHIC ARTHRITIS

KW - ALPHA MONOCLONAL-ANTIBODY

KW - INTERLEUKIN-1 RECEPTOR ANTAGONIST

KW - FAMILIAL MEDITERRANEAN FEVER

KW - PLACEBO-CONTROLLED TRIAL

KW - ACTIVE ANKYLOSING-SPONDYLITIS

KW - MODIFYING ANTIRHEUMATIC DRUGS

U2 - 10.1136/ard.2010.146852

DO - 10.1136/ard.2010.146852

M3 - Literature review

SN - 0003-4967

VL - 70

SP - I2-I36

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 1

ER -